Abstract
The effects of B cell stimulatory factor 1 (BSF-1) on the generation of human CTL and lymphokine-activated killer (LAK) cells in vitro were investigated. Both L-2 and BSF-1 were potent helper factors for the generation of antigen-specific CTL in MLC; detection of optimal BSF-1-induced CTL activity in this system occurred when BSF-1 was added to cultures after an initial period of activation during which exogenous BSF-1 was not present. In contrast to IL-2, BSF-1 failed to induce an LAK cell population, as detected with Daudi tumor targets, in cultures that had not been allosensitized. Furthermore, when both lymphokines were added together at culture initiation, BSF-1 inhibited the IL-2-driven generation of cytolytic cells. The differential ability of BSF-1 to promote the generation of CTL but not LAK could have important implications for lymphokine-mediated immunotherapy.
MeSH Terms
Cell Differentiation
Cell Division
Cells, Cultured
Humans
Interleukin-2/pharmacology
Interleukin-4
Interleukins/pharmacology
Killer Cells, Natural/cytology
Lymphocyte Activation
Lymphokines/pharmacology
Recombinant Proteins/pharmacology
T-Lymphocytes, Cytotoxic/cytology
Chemicals
Interleukin-2
Interleukins
Lymphokines
Recombinant Proteins
Interleukin-4
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Widmer M B
Immunex Corporation, Seattle, Washington 98101.
Acres R B
Sassenfeld H M
Grabstein K H
References (23)
23 references, click to expand
-
Regulation of murine T cell proliferation by B cell stimulatory factor-1.
J Immunol. 1987 Aug 15;139(4):1148-53
PMID: 3112226
-
Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.
J Immunol. 1987 Jul 1;139(1):285-94
PMID: 3108401
-
In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.
J Immunol. 1980 Jul;125(1):238-45
PMID: 6966652
-
Identification of a T cell-derived b cell growth factor distinct from interleukin 2.
J Exp Med. 1982 Mar 1;155(3):914-23
PMID: 6977612
-
A differentiation factor required for the expression of cytotoxic T-cell function.
Nature. 1982 Apr 22;296(5859):754-7
PMID: 6803172
-
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
J Exp Med. 1982 Jun 1;155(6):1823-41
PMID: 6176669
-
Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses.
J Exp Med. 1982 Jun 1;155(6):1876-81
PMID: 6978927
-
Characterization of helper factors distinct from interleukin 2 necessary for the generation of allospecific cytolytic T lymphocytes.
J Immunol. 1983 Feb;130(2):756-62
PMID: 6184404
-
Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.
J Immunol. 1983 Feb;130(2):763-7
PMID: 6600253
-
Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.
J Exp Med. 1983 Feb 1;157(2):530-46
PMID: 6401797
-
Induction of cytotoxic T cell function requires sequential action of three different lymphokines.
J Immunol. 1983 Jun;130(6):2508-10
PMID: 6602167
-
Three different signals are required for the induction of cytolytic T lymphocytes from resting precursors.
J Immunol. 1983 Aug;131(2):606-10
PMID: 6602842
-
Biological activity of recombinant human interleukin-2 produced in Escherichia coli.
Science. 1984 Mar 30;223(4643):1412-4
PMID: 6367046
-
Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
J Immunol. 1984 Sep;133(3):1664-70
PMID: 6205090
-
Lymphokine purification by reversed-phase high-performance liquid chromatography.
J Chromatogr. 1984 Jul 27;296:171-9
PMID: 6332819
-
Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.
J Immunol. 1985 Mar;134(3):1644-52
PMID: 3871453
-
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.
N Engl J Med. 1985 Dec 5;313(23):1485-92
PMID: 3903508
-
Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells.
J Immunol. 1986 Jul 15;137(2):502-11
PMID: 2424971
-
B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.
J Exp Med. 1986 Aug 1;164(2):580-93
PMID: 2941517
-
Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.
Proc Natl Acad Sci U S A. 1986 Aug;83(16):5894-8
PMID: 3016727
-
B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes.
J Exp Med. 1987 Jan 1;165(1):157-72
PMID: 3098893
-
Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor.
Nature. 1987 Apr 23-29;326(6115):795-8
PMID: 3494950
-
Production of IL-1 alpha and IL-1 beta by clones of EBV transformed, human B cells.
Mol Immunol. 1987 May;24(5):479-85
PMID: 2821386